Are you Dr. Klekotka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 44 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4921 Parkview Pl
Suite 5b
Saint Louis, MO 63110Phone(314) 362-2643Fax(314) 454-5626- Is this information wrong?
Summary
- Dr. Paul Klekotka, MD is a board certified dermatologist in Saint Louis, Missouri. He is currently licensed to practice medicine in California.
Education & Training
Barnes-Jewish HospitalResidency, Dermatology, 2003 - 2006- Barnes-Jewish HospitalInternship, Internal Medicine, 2002 - 2003
Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2010 - 2022- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish Chandra Choudhary, Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R Crain, Carlee Moser, Michael Hughes, Justin Ritz, Ruy M. Ribeiro, Ruian Ke, Jo...> ;medRxiv. 2021 Sep 15
- First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19.Peter Chen, Gourab Datta, Ying Grace Li, Jenny Y. Chien, Karen L. Price, Emmanuel Chigutsa, Patricia Brown-Augsburger, Josh Poorbaugh, Jeffrey Fill, Robert J. Benschop...> ;Clinical Pharmacology & Therapeutics. 2021 Oct 16
- 26 citationsBamlanivimab plus Etesevimab in Mild or Moderate Covid-19.Michael Dougan, Ajay Nirula, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Ch...> ;The New England Journal of Medicine. 2021 Jul 14
- Join now to see all
Grant Support
- Role Of NK Cells In Contact HypersensitivityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2009
